highly significantp < 0.001
The difference in survival probabilities from the time of diagnosis and from the start of treatment with purine analogs between the two groups was highly significant (p < 0.001).
The difference in survival probabilities from the time of diagnosis and from the start of treatment with purine analogs between the two groups was highly significant (p < 0.001).